CTSO
Cytosorbents Crp
NASDAQ: CTSO · HEALTHCARE · MEDICAL DEVICES
$0.57
-5.80% today
Updated 2026-05-06
Market cap
$38.95M
P/E ratio
—
P/S ratio
1.05x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Cytosorbents Crp (CTSO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-22.10%
Operating margin
-43.90%
ROE
-96.40%
ROA
-19.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-7.67M | — | — | — |
| 2007 | — | $-3.35M | — | — | — |
| 2008 | — | $-3.02M | — | — | — |
| 2009 | — | $-2.74M | — | — | — |
| 2010 | — | $-2.91M | — | — | — |
| 2011 | $36078.00 | $-5.48M | 67.40% | -12,297.71% | -15,193.88% |
| 2012 | $151574.00 | $-3.66M | -110.65% | -2,303.06% | -2,416.98% |
| 2013 | $821787.00 | $-4.68M | -132.61% | -573.53% | -569.22% |
| 2014 | $3.15M | $-9.32M | 32.15% | -231.45% | -296.38% |
| 2015 | $4.06M | $-8.13M | 45.45% | -229.39% | -200.50% |
| 2016 | $8.21M | $-11.94M | 51.82% | -140.04% | -145.49% |
| 2017 | $13.38M | $-8.46M | 58.76% | -73.55% | -63.23% |
| 2018 | $20.25M | $-17.21M | 63.02% | -76.95% | -84.98% |
| 2019 | $22.77M | $-19.27M | 67.65% | -83.34% | -84.63% |
| 2020 | $39.45M | $-7.84M | 71.98% | -26.28% | -19.86% |
| 2021 | $40.11M | $-24.56M | 72.46% | -56.71% | -61.23% |
| 2022 | $34.69M | $-32.81M | 59.77% | -90.87% | -94.59% |
| 2023 | $31.08M | $-29.25M | 70.62% | -102.78% | -94.09% |
| 2024 | $35.59M | $-20.72M | 70.59% | -47.16% | -58.21% |
| 2025 | $37.06M | $-8.20M | 71.48% | -38.42% | -22.12% |